BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7896209)

  • 1. Early hemostatic alterations following bone marrow transplantation: a prospective study.
    Vannucchi AM; Rafanelli D; Longo G; Bosi A; Guidi S; Saccardi R; Filimberti E; Cinotti S; Grossi A; Morfini M
    Haematologica; 1994; 79(6):519-25. PubMed ID: 7896209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.
    Lee JH; Lee KH; Kim S; Lee JS; Kim WK; Park CJ; Chi HS; Kim SH
    Bone Marrow Transplant; 1998 Nov; 22(9):883-8. PubMed ID: 9827816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
    Catani L; Gugliotta L; Mattioli Belmonte M; Vianelli N; Gherlinzoni F; Miggiano MC; Belardinelli AR; Rosti G; Calori E; Bandini G
    Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
    Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
    Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
    Bazarbachi A; Scrobohaci ML; Gisselbrecht C; Marolleau JP; Mansi A; Brice P; Gorra P; Drouet L
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
    Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
    Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease.
    Salat C; Holler E; Reinhardt B; Kolb HJ; Seeber B; Ledderose G; Mittermueller J; Duell T; Wilmanns W; Hiller E
    Bone Marrow Transplant; 1994 Nov; 14(5):747-50. PubMed ID: 7889007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activation of endothelium-dependent hemostatic factors following bone marrow transplantation].
    Tsakiris DA; Marbet GA; Tichelli A; Gratwohl A; Speck B
    Schweiz Med Wochenschr; 1995 Mar; 125(9):416-9. PubMed ID: 7892569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tendency to thrombosis following bone marrow transplantation?].
    Tsakiris DA; Huser B; Gratwohl A; Marbet GA
    Schweiz Med Wochenschr; 1991 Mar; 121(10):341-3. PubMed ID: 1902984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral glutamine protects hepatic function during bone marrow transplantation.
    Brown SA; Goringe A; Fegan C; Davies SV; Giddings J; Whittaker JA; Burnett AK; Poynton CH
    Bone Marrow Transplant; 1998 Aug; 22(3):281-4. PubMed ID: 9720743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
    Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
    Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M; Ringdén O
    Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.
    Testa S; Manna A; Porcellini A; Maffi F; Morstabilini G; Denti N; Macchi S; Rosti G; Porcellini G; Cassi D; Ferrari L
    Bone Marrow Transplant; 1996 Aug; 18(2):383-8. PubMed ID: 8864450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral coagulation and early complications after allogeneic bone marrow transplantation.
    Nürnberger W; Kruck H; Mauz-Körholz C; Burdach S; Göbel U
    Klin Padiatr; 1997; 209(4):209-15. PubMed ID: 9293452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation.
    Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH
    Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium and bone marrow transplantation.
    Catani L; Gugliotta L; Vianelli N; Nocentini F; Baravelli S; Bandini G; Cirio TM; Tura S
    Bone Marrow Transplant; 1996 Feb; 17(2):277-80. PubMed ID: 8640179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor as a marker of endothelial cell activation following BMT.
    Collins PW; Gutteridge CN; O'Driscoll A; Blair S; Jones L; Aitchison R; Kelsey SM; Chopra R; Goldstone A; Newland AC
    Bone Marrow Transplant; 1992 Dec; 10(6):499-506. PubMed ID: 1490199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation].
    Salat C; Holler E; Reinhardt B; Kolb HJ; Pihusch R; Neumeister P; Hiller E
    Med Klin (Munich); 1994 May; 89(5):245-7. PubMed ID: 8052177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the natural anticoagulants following bone marrow transplantation.
    Harper PL; Jarvis J; Jennings I; Luddington R; Marcus RE
    Bone Marrow Transplant; 1990 Jan; 5(1):39-42. PubMed ID: 2137021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.